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Background: There are striking socioeconomic differences in life expectancy, but less is known about inequalities
in healthy life expectancy and disease-free life expectancy. We estimated socioeconomic differences in health
expectancies in four studies in England, Finland, France and Sweden. Methods: We estimated socioeconomic
differences in health expectancies using data drawn from repeated waves of the four cohorts for two
indicators: (i) self-rated health and (ii) chronic diseases (cardiovascular, cancer, respiratory and diabetes).
Socioeconomic position was measured by occupational position. Multistate life table models were used to
estimate healthy and chronic disease-free life expectancy from ages 50 to 75. Results: In all cohorts, we found
inequalities in healthy life expectancy according to socioeconomic position. In England, both women and men in
the higher positions could expect 82–83% of their life between ages 50 and 75 to be in good health compared to
68% for those in lower positions. The figures were 75% compared to 47–50% for Finland; 85–87% compared to
77–79% for France and 80–83% compared to 72–75% for Sweden. Those in higher occupational positions could
expect more years in good health (2.1–6.8 years) and without chronic diseases (0.5–2.3 years) from ages 50 to 75.
Conclusion: There are inequalities in healthy life expectancy between ages 50 and 75 according to occupational
position. These results suggest that reducing socioeconomic inequalities would make an important contribution to
extending healthy life expectancy and disease-free life expectancy.
. .. . . .. . .. . .. . .. . .. . .. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . .. . . .. . .. . .. . .. . .. . .. . .. . .. . .
Introduction
In Europe, life expectancy continues to rise
1 and disability rates in
later life have been falling in Europe and the USA since the
1980s.2,3 However, there are concerns that increases in healthy,
disease-free years of life (health expectancies), are no longer
keeping pace with those in life expectancy, leading to an
expansion of time with morbidity.4,5 Furthermore, there are
striking socioeconomic differences in life expectancy, but the
extent to which these also exist in health expectancies remains
unclear.1
The few studies that have examined socioeconomic inequalities in
health expectancies found that those in lower socioeconomic groups
are doubly disadvantaged by shorter life expectancy and more years
spent in ill health.6,7 Results showed that people with higher
education not only live longer but spend more years in better
health than those with a lower education.8–12 Even fewer studies
have investigated occupational socioeconomic position, a more
proximal measure which may better reflect adulthood circum-
stances,13 and these also suggest that there are socioeconomic dif-
ferences in health expectancies.14,15 Given that many governments
expect people to extend their working lives and that good health is
associated with extended working, it is important to study
socioeconomic inequalities in health expectancies. In this context,
occupational position may be a more relevant indicator than
education.
The aim of this multi-cohort study is to contribute to knowledge
on inequalities in health expectancies at older ages. We examined
occupational class differences in both healthy life expectancy and
chronic disease-free life expectancy between the ages of 50 and
75 years for men and women from four cohorts with longitudinal
data on health spanning several years.
Methods
The data came from four cohort studies in England, Finland, France
and Sweden. People were included from the first observation with
valid data on self-rated health and chronic diseases when they were
aged 50 years or older.16 We limited our estimation of partial life
expectancy to an upper age of 75 as not all cohorts had participants
aged 75 and older.
Samples
The English data were from the first six waves of the English
Longitudinal Study of Ageing (ELSA), an open-access, nationally
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representative biennial longitudinal survey of those aged 50 and over
living in private households in England. The sample size was 11 391
people at the first wave in 2002.17 We included 9213 participants
aged 50–75 at the first wave with valid data on self-rated health and
chronic diseases.
The Finnish data came from five waves of the Finnish Public
Sector study (FPS). The FPS, established in 1997/1998, comprises
all employees with 6 month job contract in any year from 1991/
2000 to 2005 in 10 towns and 5 hospital districts in Finland. Survey
data were collected at 4-year intervals on 103 866 cohort members,
employed in the participating organizations during the survey years
1997/1998, 2000/2002, 2004, 2008 and/or 2012. Follow-up surveys
for respondents who had retired or left the organizations were
conducted in 2005, 2009 and 2013. Data from 42 978 people aged
50–75 at the first wave with valid health measures were analyzed.
The French data were taken from the GAZEL Cohort Study, set up
in 1989 among E´lectricite´ de France-Gaz de France workers, the
French national utility company, with annual waves of data
collection up to 2014. At inception in 1989, the GAZEL Cohort
Study included 20 625 volunteers (15 011 men and 5614 women)
aged 35–50 years.18 Data from 18 263 people from the first wave they
were aged 50 plus and had health data were analyzed.
The data for Sweden were from five waves of the Swedish
Longitudinal Occupational Survey of Health (SLOSH).19 The
SLOSH cohort is drawn from the Swedish Work Environment
Survey (SWES), a cross-sectional, biennial survey of a random
stratified sample of employed people aged 16–64 years who
responded to the Labour Force Survey in the same year. The first
wave of SLOSH in 2006 was a follow-up of respondents to the 2003
SWES. At wave 2 in 2008, new respondents to the 2005 SWES were
added, giving an overall sample of 18 915. This sample was re-
surveyed in 2010, 2012 and 2014. Data from 8186 people aged 50–
75 were analyzed.
Outcome measures
We defined two outcomes: (i) healthy life expectancy using self-rated
health and (ii) chronic disease-free life expectancy.
Self-rated health: All participants were asked about their health
status at each wave. Responses were categorized into good and
poor health as follows. GAZEL used an eight point scale, where
the participant indicated whether her/his health was very good (8)
to very bad (1). In line with previous research,20 the four top
response options were coded as good health. In ELSA, FPS and
SLOSH the question used a five point response format, ranging
from excellent/very good to very poor. For FPS and SLOSH, the
top two response options were grouped and categorized as ‘good
health’, and in ELSA, the top three response options were
categorized as ‘good health’. The question wordings for each
cohort are given in the online Supplementary appendix.
Chronic diseases: Presence of the following chronic diseases was
ascertained for each cohort by asking ‘has a doctor ever told you that
you have . . .’: (i) heart disease (heart attack, coronary heart disease,
angina, congestive heart failure or other heart problems), (ii) stroke
(stroke or transient ischaemic attack), (iii) chronic lung disease
(chronic bronchitis or emphysema or asthma), (iv) cancer (cancer
or a malignant tumour of any kind except skin cancer) and (v)
diabetes (diabetes or high blood sugar). Individuals were defined
as having a chronic disease if they reported one or more of these
conditions. The presence of chronic disease at baseline (first obser-
vation included in analysis) included any chronic diseases reported
before the age of 50 from available information on respondents. The
data for Sweden on chronic disease came from 2008 to 2014 waves as
the 2006 wave did not collect information on all chronic conditions.
Mortality was ascertained from linked register data with follow-up
censored on 31 December of the year in which data collection last
took place for each cohort.
Occupational position
Occupational position was coded into three groups according to the
national occupational classification: higher, intermediate and lower
occupational positions. In ELSA and SLOSH, occupational position
was based on self-reported job title; in FPS and GAZEL occupational
position was obtained from the employers’ records.
Statistical analyses
Characteristics of the participating cohorts are presented at the first
observation point, which refers to the date each participant is first
included in this analysis.
Multistate life table models were used to estimate healthy life
expectancy and chronic disease-free life expectancy between the
ages of 50 and 75 (in total 26 years). For both measures, three
health states were defined: healthy, unhealthy and dead. For self-
rated health, there were four possible transitions between these
health states, namely: healthy to unhealthy (onset), unhealthy to
healthy (recovery), healthy to dead, unhealthy to dead. For
chronic disease, there were only three possible transitions as, by
definition, recovery was not possible. The analysis included all
study participants with at least one measure of health when they
were aged 50 years or older. For each study, age-specific transition
probabilities by sex and occupational position were estimated from
multinomial logistic models with age (in years), sex and occupa-
tional position as covariates. Partial life expectancy, healthy life
expectancy and chronic disease-free life expectancy from ages 50
to 75 were then calculated from these estimated transition
probabilities using a stochastic (micro-simulation) approach.21 For
each study, individual trajectories for a simulated cohort of 100 000
persons were generated with distributions of covariates at the
starting point based on the observed study-specific prevalence by
five year age-group, sex and occupational position. Health
expectancies from age 50 to 75 were calculated as the average
from these trajectories for each occupational position and sex.
Computation of standard errors and 95% confidence intervals
(from 2.5th and 97.5th percentiles) for these multistate life table
estimates was performed using a bootstrap method with 500
replicates for the whole analysis process (multinomial analysis and
simulation steps). Analyses were conducted in SAS 9.2 using the
Stochastic Population Analysis of Complex Events programme
(http://www.cdc.gov/nchs/data_access/space.htm).21
Ethics approval
In all cohorts, participants gave their informed consent to take part.
Ethical approval was given in each of the countries from relevant
ethical committees/boards.
Results
At the first observation point when participants were included in the
analysis, the prevalence of poor self-rated health ranged from 20% in
France to 36% in Finland. Prevalence of self-reported chronic
diseases ranged from 21% in France to 33% in England (table 1).
For all cohorts, the risk of mortality or poor self-reported health
from a state of good self-reported health was higher for people in the
lowest occupational group. Correspondingly, the likelihood of
recovery from poor health was lower for people in the lowest occu-
pational group (Supplementary table S1). Risk of mortality from a
poor health state also showed a similar gradient by occupational
position.
Socioeconomic differences in healthy life expectancy
There were occupational position differences for partial life
expectancy and healthy life expectancy at age 50 in all cohorts
such that people in the lower occupational position could expect
2 of 6 European Journal of Public Health
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to live fewer total years to age 75 and to spend fewer of these years in
good health (table 2). These differences were more marked for
healthy life expectancy than partial life expectancy for all cohorts.
For example, women in England with a high occupational position
could expect to spend 83% of their life from 50 to 75 in good health
whereas the corresponding figure for English women in a lower
occupational position was 68%. Our estimates of occupational
position differences in healthy years of life lost between the ages of
50–75 ranged from 2.1 years for women in the Swedish cohort to
6.8 years for men in the Finnish cohort.
Socioeconomic differences in disease-free life
expectancy
Results from the multistate models for chronic diseases
(Supplementary table S2) showed socioeconomic differences in
risk of transition to chronic disease or mortality from a disease-
free state as well as higher risk of mortality from having a chronic
disease. For each cohort, our estimates of chronic disease-free life
expectancy (table 3) showed that, compared to those in a higher
occupational position, men and women in the lower occupational
position could expect to live fewer years without chronic diseases
between ages 50 and 75. For example, women in England in the
higher occupational grade could expect to spend 61% of their life
from 50 to 75 without chronic disease. The corresponding figure for
women in the lower occupational grade in England was 56%. Our
estimates of occupational position differences in chronic disease-free
years of life lost between the ages of 50–75 ranged from 0.5 years for
women in the French cohort to 2.3 years for men in the Finnish
cohort.
Sensitivity analyses
We conducted several sensitivity analyses. Estimates of healthy and
chronic disease-free life expectancy were very similar for occupa-
tional socioeconomic position recorded at either age 35 or at age
50. We investigated the potential impact of frequency of follow-up
on our results by repeating analyses for GAZEL with data from every
fourth wave rather than yearly intervals and found very similar
results. As chronic conditions were considered to be non-
reversible, the estimates of prevalence of chronic disease by age 50
tended to be higher for participants with more waves of data before
age 50. Therefore, we repeated analyses excluding information on
chronic conditions collected before the age of 50. As expected, this
led to higher estimates of years lived without chronic disease but
differences by socioeconomic position remained similar for each
cohort. Finally, we obtained a similar pattern of results from
analyses including information on chronic diseases from both
register and self-report data for the Finnish and Swedish cohorts.
Discussion
This cross-national multi-cohort study found socioeconomic
inequalities in both partial life expectancy and healthy life
expectancy such that socioeconomic differences in years of healthy
life lost are greater than differences in years of life lost between the
ages of 50 and 75. Compared to people in higher occupational
positions, those in lower occupational positions had a lower
expectancy of life years until age 75 and could expect to live fewer
of these years in good health. This pattern was consistent across the
four countries and observed for both men and women. There were
also socioeconomic inequalities in chronic disease-free life
expectancy, although estimates of average years lived without
diseases were lower than for average years lived in good perceived
health.
Our findings are in line with previous studies that have used
education as a measure of socioeconomic inequality that show
that those with the least level of education have the lowest health
expectancies.7–12 In our study, men and women in the lowest
compared to the highest occupational position could expect 2.1–
6.8 fewer years in good health and 0.5–2.3 fewer years lived
without chronic disease between the ages of 50 and 75.
To our knowledge, few previous studies have reported differences
in health expectancies by occupational social position. These studies
also found socioeconomic inequalities in health expectancies but
there were some differences when comparing inequalities for men
and women. A previous study of socioeconomic inequalities in
disability-free life expectancy in the UK found greater social class
inequalities amongst women compared to men.15 This is in line with
our results for chronic disease where the difference in chronic
disease-free life expectancy between the low and high occupational
class was 1.8 years for English women and 1.0 years for English men
but not consistent with our results for self-rated health where we
found similar occupational class inequalities in men and women. As
with the current study, an earlier study in France found similar
Table 1 Prevalence (%) of sociodemographic and health characteristics at the first observation pointa
ELSA FPS GAZEL SLOSH
Sample size 9213 42 978 18 263 8186
Sex (%)
Male 46.4 19.9 73.8 45.7
Female 53.6 80.1 26.2 54.3
Age-group (%)
50–54 21.9 70.5 94.5 41.8
55–59 24.2 24.9 3.9 24.2
60–64 18.7 4.5 1.3 23.5
65–69 18.9 0.1 0.3 10.2
70–74 16.3 – 0.1 0.3
Socioeconomic position (%)
High grade 30.0 29.9 14.1 19.3
Middle grade 23.5 49.0 57.8 44.7
Low grade 46.5 21.2 28.2 36.0
Self-rated health (%)
Good 75.0 63.4 79.9 77.9
Poor 25.0 36.0 20.1 22.1
Chronic health conditionsb
No 67.1 74.1 79.5 80.7
Yes 32.9 25.9 20.5 19.3
a: The first observation point refers to the date each participant is for the first time included in the dataset.
b: Presence of chronic health conditions includes illness reported at or before the first observation point.
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social class differences in healthy life expectancy for men and
women.14 However, social class differences in chronic disease-free
life expectancy at age 50 were wider for French women (4.4 years)
than for French men (3.0 years) in the earlier study whereas we
found slightly wider social class differences for French men
(1.6 years) than for French women (0.5 years). This may reflect
methodological differences as the previous study used information
from a national survey and their measure of chronic disease was
based on a single question.
Estimates of absolute socioeconomic differences in healthy and
chronic disease-free life expectancy varied across the four cohorts
and were most marked in the Finnish cohort, particularly for self-
rated health. Although there have been two previous cross-national
studies of socioeconomic inequalities in health expectancies, these
investigated educational inequalities in disability-free life
expectancy.8,9 As stated by Pongiglione et al. in their systematic
literature review of inequalities in health expectancies, estimates of
years of healthy life lost tend to vary according to the definition of
health making it difficult to compare results from different studies.7
Our finding that estimates of average years lived without chronic
disease were lower than for average years lived in good health was
consistent with findings from studies with multiple health indicators
included in the review by Pongligione et al.7
Strengths of our study include the use of data from prospective
cohorts from four different countries, with several measurements of
health over time, long follow-up, and high quality harmonised data.
Our multistate life table method of estimating healthy life
expectancy and chronic disease-free life expectancy using longitu-
dinal data provides internally consistent results for each cohort.
However, there were some limitations. Not all cohorts were
nationally representative. Whereas ELSA is a national survey, the
others were occupational cohorts that were either designed to be
representative of all employees (SLOSH) or specific employment
sectors (FPS and GAZEL). Participants in longitudinal studies
tend to be healthier than the general population and more
disadvantaged groups tend to be underrepresented, and additionally
there were socioeconomic differences in attrition rates.22–24
However, past research from our studies have shown similar
socioeconomic differentials in health to those seen nationally
implying that our results are generalizable to a wider population.25
The cohorts did not have entirely consistent definitions of self-rated
health and this could contribute to some of the cohort differences in
Table 2 Partial life expectancy, healthy life expectancy and proportion of life spent in good self-rated health between the ages of 50 and 75
by socioeconomic position
Partial life expectancy between the ages of 50 and 75
Life expectancy 95% CI Healthy life
expectancy
95% CI Unhealthy life
expectancy
95% CI % spent in
good health
Men
ELSA
High grade 24.1 24.0, 24.4 19.8 19.4, 20.3 4.3 4.0, 4.7 82.2
Middle grade 23.7 23.4, 24.0 18.2 17.6, 18.9 5.5 4.9, 5.9 76.8
Low grade 22.9 22.6, 23.3 15.5 14.9, 16.1 7.4 7.0, 7.9 67.7
Highlow 1.2 4.3 3.1 14.5
FPS
High grade 24.5 24.4, 24.7 18.5 18.2, 19.0 6.0 5.6, 6.3 75.4
Middle grade 24.1 23.9, 24.4 15.4 15.1, 16.0 8.7 8.2, 9.1 63.8
Low grade 23.4 23.2, 23.9 11.7 11.3, 12.3 11.7 11.2, 12.2 49.9
Highlow 1.1 6.8 5.7 25.5
GAZEL
High grade 24.8 24.6, 25.0 21.6 21.3, 21.8 3.2 3.0, 3.4 87.1
Middle grade 24.3 24.2, 24.4 20.5 20.3, 20.7 3.9 3.7, 4.0 84.2
Low grade 23.8 23.6, 24.0 18.8 18.6, 19.1 5.3 5.0, 5.6 79.1
Highlow 1.0 2.8 2.1 8.0
SLOSH
High grade 25.6 25.4, 25.9 20.4 19.8, 21.1 5.1 4.5, 5.8 79.9
Middle grade 25.2 24.9, 25.5 19.7 19.2, 20.4 5.5 4.9, 5.9 78.2
Low grade 25.3 24.9, 25.5 18.1 17.4, 18.6 7.2 6.6, 7.8 71.6
Highlow 0.3 2.3 2.1 8.3
Women
ELSA
High grade 24.8 24.6, 25.0 20.6 20.0, 21.0 4.2 3.9, 4.8 83.0
Middle grade 24.5 24.2, 24.7 19.1 18.6, 19.6 5.4 4.9, 5.9 78.1
Low grade 23.9 23.6, 24.2 16.1 15.5, 16.7 7.8 7.3, 8.3 67.5
Highlow 0.9 4.5 3.6 15.5
FPS
High grade 25.1 25.0, 25.3 18.9 18.7, 19.2 6.2 6.0, 6.5 75.3
Middle grade 24.9 24.8, 25.0 16.3 16.1, 16.6 8.6 8.4, 8.8 65.5
Low grade 24.6 24.4, 24.8 12.4 12.1, 12.8 12.2 11.8, 12.5 50.5
Highlow 0.5 6.5 6.0 24.8
GAZEL
High grade 25.3 25.1, 25.5 21.6 21.2, 21.9 3.7 3.4, 4.1 85.4
Middle grade 25.0 24.8, 25.2 20.5 19.9, 20.4 4.5 4.3, 4.7 82.0
Low grade 24.7 24.5, 24.9 18.9 18.0, 18.8 5.7 5.6, 6.0 76.7
Highlow 0.6 2.7 2.0 8.7
SLOSH
High grade 25.7 25.5, 25.9 21.3 20.7, 21.9 4.4 3.9, 5.0 82.8
Middle grade 25.4 25.3, 25.6 20.8 20.3, 21.1 4.7 4.4, 5.0 81.7
Low grade 25.5 25.1, 25.8 19.2 18.6, 19.6 6.3 5.8, 6.8 75.3
Highlow 0.2 2.1 1.9 7.5
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absolute healthy life expectancy. However, relative differences by
socioeconomic group were consistent across the cohorts. We used
five chronic diseases, namely heart disease, stroke, chronic lung
disease, cancer and diabetes, to estimate chronic disease-free life
expectancy. Although musculoskeletal disorders were measured in
each cohort, it was not possible to develop a harmonized measure of
musculoskeletal disorders across the cohorts. As these disorders are
very common at older ages and related to poorer functioning and
quality-of-life, future studies of chronic disease-free life expectancy
should include musculoskeletal disorders.
There were differences in frequency of follow-up intervals between
studies ranging from annual to four yearly waves of data collection.
To assess the possible impact of this, we repeated analyses for the
GAZEL cohort using data from every fourth wave and obtained
similar results. Our study provides estimates of healthy life
expectancy and chronic disease-free life expectancy from age 50 to
75 so future studies are needed to investigate socioeconomic differ-
ences in years of life spent in good health and without chronic
disease at older ages. Finally, we were not able to analyze changes
over time in health expectancies by socioeconomic position. Results
from a study comparing health expectancies in 1991 and 2011 in
England showed a relative compression of morbidity for self-
perceived health, with an increase in the proportion of life spent
in good health.26 Future research is needed to investigate
socioeconomic differences in changes in health expectancies over
time.
Conclusions
A better understanding of the future health of older people is of
crucial policy importance as it affects public expenditure on
income, health and long-term care needs of ageing populations.27
Furthermore, healthy and disease-free life expectancy is also
important for work participation, given the actions by most
European governments to extend working lives.28 Our study
highlights the importance of reducing social class differences in
health expectancies as part of efforts to achieve that target.
Supplementary data
Supplementary data are available at EURPUB online.
Table 3 Partial life expectancy, chronic disease-free life expectancy and proportion of life spent without chronic disease between the ages
of 50 and 75 by socioeconomic position
Partial life expectancy between the ages of 50 and 75
Life expectancya 95% CI Chronic disease-free
life expectancy
95% CI Life expectancy with
chronic diseases
95% CI % spent without
chronic disease
Men
ELSA
High grade 24.1 23.9, 24.3 13.8 12.7, 14.9 10.3 9.3, 11.3 57.4
Middle grade 23.6 23.3, 24.0 13.2 11.6, 14.4 10.4 9.4, 11.8 56.1
Low grade 23.1 22.8, 23.4 12.8 11.5, 13.8 10.3 9.4, 11.5 55.2
Highlow 1.0 1.0 0.0 2.2
FPS
High grade 24.4 24.2, 24.7 13.7 12.9, 13.9 10.8 10.5, 11.6 55.9
Middle grade 24.1 23.6, 24.3 12.4 11.7, 12.9 11.7 11.1, 12.3 51.3
Low grade 23.5 23.2, 23.8 11.4 11.0, 11.9 12.0 11.4, 12.6 48.7
Highlow 0.9 2.3 1.2 7.2
GAZEL
High grade 24.8 24.6, 25.0 15.5 15.1, 16.1 9.3 8.8, 9.7 62.5
Middle grade 24.3 24.2, 24.4 14.9 14.6, 15.2 9.4 9.1, 9.7 61.3
Low grade 23.8 23.6, 24.0 13.9 13.6, 14.4 9.9 9.4, 10.2 58.4
Highlow 1.0 1.6 0.6 4.1
SLOSH
High grade 25.6 25.4, 25.9 15.0 13.6, 16.5 10.7 9.1, 12.1 58.4
Middle grade 25.1 24.7, 25.4 14.5 13.3, 15.6 10.6 9.6, 11.8 57.8
Low grade 25.1 24.7, 25.4 13.6 12.6, 14.5 11.6 10.6, 12.5 53.9
Highlow 0.5 1.4 0.9 4.5
Women
ELSA
High grade 24.8 24.6, 24.9 15.2 13.8, 16.5 9.6 8.4, 10.9 61.3
Middle grade 24.5 24.3, 24.7 15.2 13.6, 16.4 9.2 8.1, 10.8 62.2
Low grade 24.0 23.8, 24.3 13.4 12.2, 14.6 10.6 9.4, 11.916 55.9
Highlow 0.8 1.8 1.0 5.4
FPS
High grade 25.1 25.0, 25.2 13.3 12.9, 13.7 11.9 11.5, 12.2 52.8
Middle grade 24.9 24.8, 25.0 13.5 13.1, 13.6 11.4 11.3, 11.8 54.0
Low grade 24.5 24.4, 24.8 12.6 12.2, 13.1 11.9 11.5, 12.5 51.5
Highlow 0.6 0.7 0.0 1.3
GAZEL
High grade 25.3 25.1, 25.5 15.7 14.8, 16.9 9.7 8.3, 10.5 61.9
Middle grade 25.0 24.8, 25.1 15.6 15.2, 16.0 9.4 9.0, 9.8 62.4
Low grade 24.7 24.5, 24.9 15.2 14.8, 15.7 9.5 9.0, 9.9 61.6
Highlow 0.6 0.5 0.2 0.3
SLOSH
High grade 25.8 25.6, 26.0 16.7 15.5, 18.2 9.1 7.5, 10.3 64.9
Middle grade 25.4 25.1, 25.6 17.0 16.0, 17.8 8.4 7.5, 9.2 66.9
Low grade 25.4 25.0, 25.6 15.3 14.3, 16.5 10.1 8.9, 11.0 60.3
Highlow 0.4 1.4 1.0 4.6
a: Due to the micro-simulation approach, the partial LE presented in this column may differ slightly from those in table2.
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Key points
 Few studies have examined socioeconomic differences in
health expectancies and most of these have used education
as a measure of socioeconomic position.
 Occupational socioeconomic position may be a more
relevant measure, particularly in the context of extending
working lives.
 There were inequalities in healthy life expectancy and
chronic disease-free life expectancy between ages 50 and 75
according to occupational position.
 Men and women in low occupational positions had a lower
expectancy of life years until age 75 and could expect to live
fewer of these years in good health or without chronic
disease.
 Reducing socioeconomic differences in health expectancies
should be part of policies aimed at extending the working
lives of people aged 50 and over.
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